PT - JOURNAL ARTICLE AU - Watt, Anne E. AU - Sherry, Norelle L. AU - Andersson, Patiyan AU - Lane, Courtney R. AU - Johnson, Sandra AU - Wilmot, Mathilda AU - Horan, Kristy AU - Sait, Michelle AU - Ballard, Susan A. AU - Crachi, Christina AU - Beck, Dianne J. AU - Marshall, Caroline AU - Kainer, Marion AU - Stuart, Rhonda AU - McGrath, Christian AU - Kwong, Jason C. AU - Bass, Pauline AU - Kelley, Peter G. AU - Crowe, Amy AU - Guy, Stephen AU - Macesic, Nenad AU - Smith, Karen AU - Williamson, Deborah A. AU - Seemann, Torsten AU - Howden, Benjamin P. TI - State-wide Genomic Epidemiology Investigations of COVID-19 Infections in Healthcare Workers – Insights for Future Pandemic Preparedness AID - 10.1101/2021.09.08.21263057 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.08.21263057 4099 - http://medrxiv.org/content/early/2021/09/13/2021.09.08.21263057.short 4100 - http://medrxiv.org/content/early/2021/09/13/2021.09.08.21263057.full AB - Background COVID-19 has resulted in many infections in healthcare workers (HCWs) globally. We performed state-wide SARS-CoV-2 genomic epidemiological investigations to identify HCW transmission dynamics and provide recommendations to optimise healthcare system preparedness for future outbreaks.Methods Genome sequencing was attempted on all COVID-19 cases in Victoria, Australia. We combined genomic and epidemiologic data to investigate the source of HCW infections across multiple healthcare facilities (HCFs) in the state. Phylogenetic analysis and fine-scale hierarchical clustering were performed for the entire Victorian dataset including community and healthcare cases. Facilities provided standardised epidemiological data and putative transmission links.Findings Between March and October 2020, approximately 1,240 HCW COVID-19 infection cases were identified; 765 are included here. Genomic sequencing was successful for 612 (80%) cases. Thirty-six investigations were undertaken across 12 HCFs. Genomic analysis revealed that multiple introductions of COVID-19 into facilities (31/36) were more common than single introductions (5/36). Major contributors to HCW acquisitions included mobility of staff and patients between wards and facilities, and characteristics and behaviours of individual patients including super-spreading events. Key limitations at the HCF level were identified.Interpretation Genomic epidemiological analyses enhanced understanding of HCW infections, revealing unsuspected clusters and transmission networks. Combined analysis of all HCWs and patients in a HCF should be conducted, supported by high rates of sequencing coverage for all cases in the population. Established systems for integrated genomic epidemiological investigations in healthcare settings will improve HCW safety in future pandemics.Funding The Victorian Government, the National Health and Medical Research Council Australia, and the Medical Research Future Fund.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Microbiological Diagnostic Unit Public Health Laboratory receives funding from the State Government of Victoria. This work was funded by the National Health & Medical Research Council (NHMRC) through the Medical Research Future Fund (MRFF): Coronavirus Research Response: 2020 Tracking COVID-19 in Australia using Genomics Grant Opportunity (MRF9200006). NLS was supported by an Australian Government Research Training Program (RPT) scholarship (GNT1093468). BPH was supported by an NHMRC Investigator Grant (GNT1196103).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was received from the University of Melbourne Human Research Ethics Committee (study number 1954615.4).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll consensus sequences and Illumina sequencing reads are available at https://github.com/MDU-PHL/COVID19-paper. Sequence accession numbers can be found in Supplementary Table 1 (note: some cases were included in investigations at more than one facility).